ADMS - Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q4 2020 Results - Earnings Call Transcript

Adamas Pharmaceuticals, Inc. (ADMS) Q4 2020 Earnings Conference Call February 23, 2021 4:30 PM ET Company Participants Peter Vozzo – Investor Relations Representative Neil McFarlane – Chief Executive Officer Vijay Shreedhar – Chief Commercial Officer Chris Prentiss – Chief Financial Officer Conference Call Participants Marc Goodman – SVB Leerink Stacy Ku – Cowen and Company Jason Butler – JMP Securities David Amsellem – Piper Sandler Tim Lugo – William Blair Tazeen Ahmad – Bank of America Serge Belanger – Needham & Company Presentation Operator Welcome to the Adamas Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Peter Vozzo, Investor Relations Representative for Adamas Pharmaceuticals. Please go

For further details see:

Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q4 2020 Results - Earnings Call Transcript